Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
Biochemical Pharmacology|September 18, 2013
OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosisLi-Yuan Bai, Jing-Ru Weng, Chang-Fang Chiu, et al.
Stem Cells (Dayton, Ohio)|June 3, 2016
Enhancer of Zeste Homolog 2 and Histone Deacetylase 9c Regulate Age-Dependent Mesenchymal Stem Cell Differentiation into Osteoblasts and AdipocytesYa-Huey Chen, Chiao-Chen Chung, Yu-Chia Liu, et al.
Leukemia & Lymphoma|February 1, 2017
Deferasirox has strong anti-leukemia activity but may antagonize theanti-leukemia effect of doxorubicinYu-Chien Chang, Wen-Jyi Lo, Yu-Ting Huang, et al.
Future Oncology (London, England)|October 11, 2013
Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinomaChing-Chan Lin, Tzu-Ting Chen, Chen-Yuan Lin, et al.
Protein and Peptide Letters|December 29, 2023
Advances in Research on Protein Arginine Methyltransferase 2: Functions and DiseasesZhen-Qi Min, Ming-Jun Jiang, Xi-Lian Liu, et al.
Hematology (Amsterdam, Netherlands)|July 3, 2024
Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in TaiwanChieh-Lin Jerry Teng, Su-Peng Yeh, Tsai-Yun Chen, et al.
Clinical Medicine Insights. Oncology|October 31, 2023
Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair StudyLing-Chiao Teng, Yu-Min Liao, Jyh-Pyng Gau, et al.
Future Oncology (London, England)|July 19, 2022
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemiaVladimir Ivanov, Su-Peng Yeh, Jiri Mayer, et al.
Oncology Letters|January 19, 2019
Outcomes of stage II-IV upper-tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancerYi-Huei Chang, Po-Jen Hsiao, Guang-Heng Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 10, 2013
Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantationSu-Peng Yeh, Woei-Chung Lo, Ching-Yun Hsieh, et al.
Pageof 22